722 related articles for article (PubMed ID: 19952382)
1. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
2. Foam and liquid sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009; 24 Suppl 1():62-72. PubMed ID: 19307442
[TBL] [Abstract][Full Text] [Related]
3. Complications and side-effects of foam sclerotherapy.
Guex JJ
Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial to evaluate the safety and efficacy of transluminal injection of foam sclerotherapy compared with ultrasound-guided foam sclerotherapy during endovenous catheter ablation in patients with varicose veins.
Watanabe S; Okamura A; Iwamoto M; Nagai H; Sumiyoshi A; Tanaka K; Suzuki S; Tanaka H; Iwakura K; Fujii K
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):75-81.e1. PubMed ID: 34252576
[TBL] [Abstract][Full Text] [Related]
5. Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.
Beckitt T; Elstone A; Ashley S
Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):115-9. PubMed ID: 21531588
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
7. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy-- assessment of a presumed safety-measure procedure.
Ceulen RP; Jagtman EA; Sommer A; Teule GJ; Schurink GW; Kemerink GJ
Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):772-6. PubMed ID: 20926321
[TBL] [Abstract][Full Text] [Related]
8. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity.
Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):407-13. PubMed ID: 20547080
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.
Darke SG; Baker SJ
Br J Surg; 2006 Aug; 93(8):969-74. PubMed ID: 16739097
[TBL] [Abstract][Full Text] [Related]
10. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.
Cavezzi A; Tessari L
Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
King JT; O'Byrne M; Vasquez M; Wright D;
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
[TBL] [Abstract][Full Text] [Related]
13. Vein diameter is a predictive factor for recanalization in treatment with ultrasound-guided foam sclerotherapy.
Toniolo J; Chiang N; Munteanu D; Russell A; Hao H; Chuen J
J Vasc Surg Venous Lymphat Disord; 2018 Nov; 6(6):707-716. PubMed ID: 30108030
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins.
Venermo M; Saarinen J; Eskelinen E; Vähäaho S; Saarinen E; Railo M; Uurto I; Salenius J; Albäck A;
Br J Surg; 2016 Oct; 103(11):1438-44. PubMed ID: 27561823
[TBL] [Abstract][Full Text] [Related]
15. Prospective Randomized Study of Ultrasound-Guided Foam Sclerotherapy Combined with Great Saphenous Vein High Ligation in the Treatment of Severe Lower Extremity Varicosis.
Yin H; He H; Wang M; Li Z; Hu Z; Yao C; Wang J; Wang S; Chang G
Ann Vasc Surg; 2017 Feb; 39():256-263. PubMed ID: 27671459
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of published reports of foam sclerotherapy: what do we know conclusively?
Myers KA; Roberts S
Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
18. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound guided foam sclerotherapy: factors associated with outcomes and complications.
Thomasset SC; Butt Z; Liptrot S; Fairbrother BJ; Makhdoomi KR
Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):389-92. PubMed ID: 20547076
[TBL] [Abstract][Full Text] [Related]
20. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
